Cargando…

PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming

Ovarian cancer is the fifth most common type of cancer afflicting women and frequently presents at a late stage with a poor prognosis. While paired box 2 (PAX2) expression is frequently lost in high-grade serous ovarian cancer, it is expressed in a subset of ovarian tumors and may play a role in tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yan, Tang, Yong, Mao, Yannan, Liu, Yingzhao, Yao, Desheng, Yang, Linkai, Garson, Kenneth, Vanderhyden, Barbara C., Wang, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010223/ https://www.ncbi.nlm.nih.gov/pubmed/31922217 http://dx.doi.org/10.3892/ijo.2020.4958

Ejemplares similares

PAX2 induces vascular-like structures in normal ovarian cells and ovarian cancer
por: Alwosaibai, Kholoud, et al.
Publicado: (2022)

PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state
por: Alwosaibai, Kholoud, et al.
Publicado: (2017)

Technical challenges and limitations of current mouse models of ovarian cancer
por: Garson, Kenneth, et al.
Publicado: (2012)

GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
por: Hodgkinson, Kendra, et al.
Publicado: (2018)

The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017)

Optimization of lentiviral vector production using polyethylenimine-mediated transfection
por: TANG, YONG, et al.
Publicado: (2015)

PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer
por: Chai, Hong-Juan, et al.
Publicado: (2017)

SLC7A1 Overexpression Is Involved in Energy Metabolism Reprogramming to Induce Tumor Progression in Epithelial Ovarian Cancer and Is Associated with Immune-Infiltrating Cells
por: You, Shijing, et al.
Publicado: (2022)

UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
por: Hardy, Laura R., et al.
Publicado: (2018)

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression
por: Barger, Carter J., et al.
Publicado: (2015)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018)

PAX2 Expression in Ovarian Cancer
por: Song, Huijuan, et al.
Publicado: (2013)

Proteomic and Phosphoproteomic Reprogramming in Epithelial Ovarian Cancer Metastasis
por: Frederick, Mallory I., et al.
Publicado: (2023)

PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis
por: Yun, Bo Seong, et al.
Publicado: (2022)

NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer
por: Zhu, Jinrong, et al.
Publicado: (2019)

Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
por: Kar, Siddhartha P, et al.
Publicado: (2017)

Non-canonical WNT5a regulates Epithelial-to-Mesenchymal Transition in the mouse ovarian surface epithelium
por: Abedini, Atefeh, et al.
Publicado: (2020)

Characterization of tumour microenvironment reprogramming reveals invasion in epithelial ovarian carcinoma
por: Zhang, Yuanfu, et al.
Publicado: (2023)

Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer
por: Lombardi, Simona, et al.
Publicado: (2023)

Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma
por: de Cristofaro, Tiziana, et al.
Publicado: (2016)

Downregulation of ITIH3 contributes to cisplatin-based chemotherapy resistance in ovarian carcinoma via the Bcl-2 mediated anti-apoptosis signaling pathway
por: Liu, Yingzhao, et al.
Publicado: (2022)

The significance of ovarian fibrosis
por: Landry, David A., et al.
Publicado: (2020)

17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo
por: Laviolette, Laura A, et al.
Publicado: (2014)

Transcriptional census of epithelial-mesenchymal plasticity in cancer
por: Cook, David P., et al.
Publicado: (2022)

Turning the fate of reprogramming cells from retinal disorder to regeneration by Pax6 in newts
por: Casco-Robles, Martin Miguel, et al.
Publicado: (2016)

PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors
por: Searcy, Madeline B., et al.
Publicado: (2023)

PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas
por: XIANG, LI, et al.
Publicado: (2013)

A New Spontaneously Transformed Syngeneic Model of High-Grade Serous Ovarian Cancer with a Tumor-Initiating Cell Population
por: McCloskey, Curtis W., et al.
Publicado: (2014)

Animal models of ovarian cancer
por: Vanderhyden, Barbara C, et al.
Publicado: (2003)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

Possible involvement of TGF-β-SMAD-mediated epithelial-mesenchymal transition in pro-metastatic property of PAX6
por: Jin, Meng, et al.
Publicado: (2020)

PAX6 Isoforms, along with Reprogramming Factors, Differentially Regulate the Induction of Cornea-specific Genes
por: Sasamoto, Yuzuru, et al.
Publicado: (2016)

PAX8 and MECOM are interaction partners driving ovarian cancer
por: Bleu, Melusine, et al.
Publicado: (2021)

ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription
por: Zeng, Kai, et al.
Publicado: (2020)

Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer Patients
por: Hassan, Zeinab K, et al.
Publicado: (2017)

The Involvement of RhoA and Wnt-5a in the Tumorigenesis and Progression of Ovarian Epithelial Carcinoma
por: Chen, Shuo, et al.
Publicado: (2013)

Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2019)

A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells
por: Di Palma, Tina, et al.
Publicado: (2014)

The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression
por: Sheta, Razan, et al.
Publicado: (2019)

Pax2 coordinates epithelial morphogenesis and cell fate in the inner ear
por: Christophorou, Nicolas A.D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_renq6468b6i9c88pendgin79sh